Abstract
Fetal medicine covers a broad spectrum of conditions that can be diagnosed before birth. Different disorders will require different treatment strategies and there is often an important ontogenetic aspect on how and when treatment can be implemented. Due to the limited availability there is a general lack of knowledge on how pharmacotherapy can be provided in the most efficient way. Until recently most knowledge about how different drugs are transferred and metabolized in the human fetus is based on very limited observational studies on concentrations of drugs in fetal blood and other fetal compartments. It might be that the rapid development of other non-invasive methods for fetal diagnostics such as isolation of fetal DNA and RNA in maternal serum, NMR imaging and other techniques could in the future be explored in fetal pharmacotherapy. Introduction of new treatment strategies are often based on extrapolation from experience in neonates and adults. However some fetal conditions are very specific for this time period in life. This especially entails disturbances in development as malformations, early growth restriction and several congenital disorders. Here it might be required to introduce new treatment strategies without any previous experience in humans. Example of this ethical dilemma is gene therapy for lung growth in severe cases of diaphragmatic hernia and early growth restriction. The risk–benefit issues need to be discussed in all these alternatives. However, it is likely that the concept of the human fetus as a potential patient is still in its infancy and with an improved understanding about fetal patho-physiology there will be a continued need for better knowledge of pharmacotherapy during this crucial time period in life.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adler SP, Nigro G (2009) Findings and conclusions from CMV hyperimmune globulin treatment trials. J Clin Virol 46(Suppl 4):S54–S57
Ballabio M, Nicolini U, Jowette T, Ruiz de Elvira MC, Ekins RP, Rodeck CH (1989) Maturation of thyroid function in normal human foetuses. Clin Endocrinol 31(5):565–571
Bang J, Bock JE, Trolle D (1982) Ultrasound guided fetal intravenous transfusion for severe rhesus haemolytic disease. Br Med J 284:373–374
Bergman G, Eliasson H, Bremme K, Wahren-Herlenius M, Sonesson SE (2009) Anti-Ro52/SSA antibody-exposed fetuses with prolonged atrioventricular time intervals show signs of decreased cardiac performance. Ultrasound Obstet Gynecol 34(5):543–549
Blakemore K, Hattenburg C, Stetten G et al (2004) In utero hematopoietic stem cell transplantation with haploidentical donor adult bone marrow in a canine model. Am J Obstet Gynecol 190:960–973
Boreus LO (1967) Pharmacology of the human fetus: dose-effect relationship for acetylcholine during ontogenesis. Biol Neonat 11:328–337
Carvalho JS, Prefumo F, Ciardelli V et al (2007) Evaluation of fetal arrhythmias from simultaneous pulsed wave Doppler in pulmonary artery and vein. Heart 93:1448–1453
Dalziel RD (2008) Antenatal corticosteroids for accelerating fetalö lung maturation for women at risk of preterm birth. The Cochrane collaboration. Cochrane Library 4:1–166
Derbyshire WGS (2006) Can fetuses feel pain? BMJ 332(7546):909–912
Fisk NM, Gitau R, Teixeira JM, Giannakoulopoulos X, Cameron AD, Glover VA (2001) Effect of direct fetal opioid analgesia on fetal hormonal and hemodynamic stress response to intrauterine needling. Anesthesiology 95:828–835
Flake AW, Zanjani ED (1999) In utero hematopoietic stem cell transplantation: ontogenic opportunities and biologic barriers. Blood 94:2179–2191
Flake AW, Roncarolo MG, Puck JM et al (1996) Treatment of x-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med 335:1806–1810
Frenkel LM, Brown ZA, Bryson YJ, Corey L, Unadkat JD, Hensleigh PA, Arvin AM, Prober CG, Connor JD (1991) Pharmacokinetics of acyclovir in the term human pregnancy and neonate. Am J Obstet Gynecol 164(2):569–576
Giannakoulopoulos X, Sepulveda W, Kourtis P, Glover V, Fisk NM (1994) Fetal plasma cortisol and beta-endorphin response to intrauterine needling. Lancet 344:77–81
Harrison MR, Slotnick RN, Crombleholme TM et al (1989) In-utero transplantation of fetal liver haemopoietic stem cells in monkeys. Lancet 2:1425–1427
Jacquemard F, Yamamoto M, Costa J-M, Romand S, Jaqz-Aigrain E, Dejean A, Daffos F, Ville Y (2007) Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG 114(9):1113–1121
Jaeggi ET, Fouron JC, Silverman ED et al (2004) Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation 110:1542–1548
Juchau MR, Dyer DC (1972) Pharmacology of the placenta. Pediatr Clin North Am 19:65–69
Krapp M, Kohl T, Simpson JM et al (2003) Review of diagnosis, treatment, and outcome of fetal artrial flutter compared with supraventricular tachycardia. Heart 89:913–917
Lagercrantz H, Changeux J-P (2009) The emergence of human consciousness: from fetal to neonatal life. Pediatr Res 65(3):255–260
Lanari M, Lazzarotto T, Venturi V, Papa I, Gabrielli L, Guerra B et al (2006) Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns. Pediatrics 117:76–83
Lazzarotto T, Varani S, Guerra B, Nicolosi A, Lanari M, Landini MP (2000) Prenatal indicators of congenital cytomegalovirus infection. J Pediatr 137:90–95
Le Blanc K, Gotherstrom C, Ringden O et al (2005) Fetal mesenchymal stem-cell engrafment in bone after in utero transplantation in a patient with severe osteogenesis imperfect. Transplantation 79:1607–1614
Leeder JS (2009) Developmental pharmacogenetics a general paradigm for application to neonatal pharmacology and toxicology. Clin Pharmacol Ther 86(6):678–682
Liggins GC (1969) Premature delivery of fetal lambs infused with glucocorticoids. J Endocrinol 45:515–523
Liggins GC, Howie RN (1972) A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome. Pediatrics 50:515–525
Liley AW (1963) Intrauterine transfusion of foetus in haemolytic disease. Br Med J ii:1107–1109
Mitsuda N, Tamaki H, Amino N, Hosono T, Miyai K, Tanizawa O (1992) Risk factors for developmental disorders in infants born to women with Graves’ disease. Obstet Gynecol 80(3 Pt 1):359–364
Myllynen P, Immonen E, Kummu M, Vähäkangas K (2009) Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues. Expert Opin Drug Metab Toxicol 5(12):1483–1499
Nigro G, Stuart P, La Torre R, Best A (2005) Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 353:13–21
Oudijk MA, Michon MM, Kleinman CS et al (2000) Sotalol in the treatment of fetal dysrhythmias. Circulation 101:2721–2726
Rodeck CH, Kemp JR, Holman CA, Whitmore DN, Karnicki J, Austin MA (1981) Direct intravascular fetal blood transfusion by fetoscopy in severe Rhesus isoimmunisation. Lancet 1:625–627
Simpson JM, Sharland GK (1998) Fetal tachycardias: management and outcome of 127 consecutive cases. Heart 79:576–581
Söderberg-Nauclér C (2008) HCMV microinfections in inflammatory diseases and cancer. J Clin Virol 41(3):218–223
Stone KM, Reiff-Eldridge R, White AD, Cordero JF, Brown Z, Alexander ER, Andrews EB (2004) Pregnancy outcomes following systemic prenatal acyclovir exposure: conclusions from the international acyclovir pregnancy registry, 1984–1999. Birth Defects Res A Clin Mol Teratol 70(4):201–207
Strandberg L, Winqvist O, Sonesson SE, Mohseni S, Salomonsson S, Bremme K, Buyon JP, Julkunen H, Wahren-Herlenius M (2008) Antibodies to amino acid 200–239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block. Clin Exp Immunol 154(1):30–37
Strumper D, Durieux ME, Gogarten W, Van Aken H, Hartleb K, Marcus MA (2003) Fetal plasma concentrations after intraamniotic sufentanil in chronically instrumented pregnant sheep. Anesthesiology 98:1400–1406
Teixeira JM, Glover V, Fisk NM (1999) Acute cerebral redistribution in response to invasive procedures in the human fetus. Am J Obstet Gynecol 181:1018–1025
Tiblad E, Westgren M (2008) Fetal stem-cell transplantation. Best Pract Res Clin Obstet Gynaecol 22(1):189–201
Touraine JL, Raudrant D, Royo C et al (1989) In-utero transplantation of stem cells in bare lymphocyte syndrome. Lancet I:1382
Van de Velde M, Van Schoubroech D, Lewi LE, Marcus MAE, Jani JC, Missant C et al (2005) Remifentanil for fetal immobilization and maternal sedation during fetoscopic surgery: a randomized double blind comparison with diazepam. Anesth Analg 101:251–258
Van de Velde M, Jani J, De Buck F, Deprest J (2006) Fetal pain preception and pain management. Semin Fetal Neonatal Med 11(4):232–236
Weiner CP, Williamson RA, Wenstrom KD, Sipes SL, Widness JA, Grant SS et al (1991) Management of fetal hemolytic disease by cordocenteses. II. Outcome of treatment. Am J Obstet Gynecol 165:1302–1307
Westgren M (2009) Intrauterine transplantation. Blood 113(19):4484
Westgren M, Jabbar F, Larsen JF, Rahman F, Selbing A, Stangeberg M (1988) Introduction of a programme for intravascular transfusions at severe rhesus isoimmunization. J Perinat Med 16:417–422
Westgren M, Ringden O, Eik-Nes S et al (1996) Lack of evidence of permanent engraftment after in utero fetal stem cell transplantation in congenital hemoglobinopathies. Transplantation 61:1176–1179
Westgren M, Ringden O, Bartmann P et al (2002) Prenatal t-cell reconstitution after in utero transplantation with fetal liver cells in a patient with x-linked severe combined immunodeficiency. Am J Obstet Gynecol 187:475–482
Yaffe SJ (1980) Clinical implications of perinatal pharmacology. Eur J Clin Pharmacol 18(1):3–7
Zanjani ED, Ascensao JL, Flake AW et al (1992) The fetus as an optimal donor and recipient of hemopoietic stem cells. Bone Marrow Transplant 10(Suppl 1):107–114
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Westgren, M. (2011). Fetal Medicine and Treatment. In: Seyberth, H., Rane, A., Schwab, M. (eds) Pediatric Clinical Pharmacology. Handbook of Experimental Pharmacology, vol 205. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-20195-0_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-20195-0_13
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-20194-3
Online ISBN: 978-3-642-20195-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)